In this study, we look at the metabolic effects of long-term dosing with tamoxifen, mestranol or phenobarbital on the liver. Tamoxifen, mestranol and phenobarbital have all been reported to act as promoters of hepatic tumors. While tamoxifen and mestranol are known to have estrogenic activity, in the liver phenobarbital is a non-estrogenic compound. Aqueous and lipophilic liver extracts from control and chronically treated Fisher 344 rats were evaluated by nuclear magnetic resonance spectroscopy (NMR). In both the aqueous and lipophilic sample sets, the estrogenic action of mestranol appears to be responsible for the clustering of these samples with those animals treated with tamoxifen. Phenobarbital does not have estrogenic activity and, therefore, clusters away from the estrogenic and control groups. In the lipophilic samples, the fatty acid peak (CH2) n was higher in tamoxifen-treated rats than in control, phenobarbital- or mestranol-treated rats. In the aqueous samples, serine and choline levels were higher in phenobarbital-treated rats than controls, which may be an indication that the folate–homocysteine metabolic pathways were altered.
Similar content being viewed by others
References
R.M. Bergeron S.C. Serron J.J. Rinehart G.F. Cawley W.L. Backes (1998) ArticleTitlePituitary component of the aromatic hydrocarbon-mediated expression of CYP2B and CYP2C11 Xenobiotica. 28 303–312
L.L. Cheng M.J. Ma L. Becerra et al. (1997) ArticleTitleQuantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy Proc. Natl. Acad. Sci. USA. 94 6408–6413
A.A. Colletta J.R. Benson M. Baum (1994) ArticleTitleAlternative mechanisms of action of anti-oestrogens Breast Cancer Res. Treat. 31 5–9
Y.P. Dragan S. Fahey K. Street J. Vaughan V.C. Jordan H.C. Pitot (1994) ArticleTitleStudies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats Breast Cancer Res. Treat. 31 11–25
Y.P. Dragan J. Singh H.C. Pitot (1996) ArticleTitleEffect of the separate and combined administration of mestranol and phenobarbital on the development of altered hepatic foci expressing placental form of glutathione S-transferase in the rat Carcinogenesis. 17 2043–2052
Y.P. Dragan J. Vaughan V.C. Jordan H.C. Pitot (1995) ArticleTitleComparison of the effects of tamoxifen and toremifene on liver and kidney tumor promotion in female rats Carcinogenesis. 16 2733–2741
H.A. Edmondson T.B. Reynolds B. Henderson B. Benton (1977) ArticleTitleRegression of liver cell adenomas associated with oral contraceptives Ann. Intern. Med. 86 180–182
J. Feng X. Li F. Pei X. Chen S. Li Y. Nie (2002) ArticleTitle1H NMR analysis for metabolites in serum and urine from rats administered chronically with La(NO3)3 Anal. Biochem. 301 1–7
O. Fiehn (2002) ArticleTitleMetabolomics: the link between genotypes and phenotypes Plant Mol. Biol. 48 155–171
S.A. Fuqua D.M. Wolf (1995) ArticleTitleMolecular aspects of estrogen receptor variants in breast cancer Breast Cancer Res. Treat. 35 233–241
B.J. Furr V.C. Jordan (1984) ArticleTitleThe pharmacology and clinical uses of tamoxifen Pharmacol. Ther. 25 127–205
L.G. Ganem C.R. Jefcoate (1998) ArticleTitleEndocrine factors modulate the phenobarbital-mediated induction of cytochromes P450 and phase II enzymes in a similar strain-dependent manner Toxicol. Appl. Pharmacol. 150 68–75
L.G. Ganem E. Trottier A. Anderson C.R. Jefcoate (1999) ArticleTitlePhenobarbital induction of CYP2B1/2 in primary hepatocytes: endocrine regulation and evidence for a single pathway for multiple inducers Toxicol. Appl. Pharmacol. 155 32–42
S. Garrod E. Humpfer S.C. Connor et al. (2001) ArticleTitleHigh-resolution 1H NMR and magic angle spinning NMR spectroscopic investigation of the biochemical effects of 2-bromoethanamine in intact renal and hepatic tissue Magn. Reson. Med. 45 781–790
S.L. Garrod E. Humpfer M. Spraul et al. (1999) ArticleTitleHigh resolution magic-angle-spinning 1H NMR spectroscopic studies on intact rat renal cortex and medulla Magn. Reson. Med. 41 1108–1118
R. Goodacre S. Vaidyanathan G. Bianchi D.B. Kell (2002) ArticleTitleMetabolic profiling using infusion electrospray ionisation mass spectromety for the characterisation of olive oils Analyst. 127 1457–1462
M.M. Gottardis V.C. Jordan (1988) ArticleTitleDevelopment of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration Cancer Res. 48 5183–5187
M.M. Gottardis M.E. Ricchio P.G. Satyaswaroop V.C. Jordan (1990) ArticleTitleEffect of steroidal and nonsteroidal antiestrogens on the growth of a tamoxifen-stimulated human endometrial carcinoma (EnCa101) in athymic mice Cancer Res. 50 3189–3192
M.M. Gottardis S. Robinson P. Satyaswaroop V.C. Jordan (1988) ArticleTitleContrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic nude mouse Cancer Res. 48 812–815
P. Greaves R. Goonetilleke G. Nunn J. Topham T. Orton (1993) ArticleTitleTwo-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats Cancer Res. 53 3919–3924
J.L. Griffin J.C.M. Pole J.K. Nicholson P.L. Carmichael (2003) ArticleTitleCellular environment of metabolites and a metabonomic study of tamoxifen in endometrial cells using gradient high resolution magic angle spinning 1H NMR spectroscopy Biochim. Biophys. Acta. 1619 151–158
J.L. Griffin L.A. Walker S. Garrod E. Holmes R.F. Shore J.K. Nicholson (2000) ArticleTitleNMR spectroscopy based metabonomic studies on the comparative biochemistry of the kidney and urine of the bank vole (Clethrionomys glareolus), wood mouse (Apodemus sylvaticus), white toothed shrew (Crocidura suaveolens) and the laboratory rat Comp. Biochem. Physiol. B. 127 357–367
J.L. Griffin H.J. Williams E. Sang J.K. Nicholson (2001) ArticleTitleAbnormal lipid profile of dystrophic cardiac tissue as demonstrated by one- and two-dimensional magic-angle spinning 1H NMR spectroscopy Magn. Reson. Med. 46 249–255
G.G. Harrigan R.H. LaPlante G.N. Cosma et al. (2004) ArticleTitleApplication of high-throughput Fourier-transform infrared spectroscopy in toxicology studies: contribution to a study on the development of an animal model for idiosyncratic toxicity Toxicol. Lett. 146 197–205
P. Hirsimaki Y. Hirsimaki L. Niemienen B.J. Payne (1993) ArticleTitleTamoxifen induces hepatocellular carcinoma in rat liver: a 1-year study with two antiestrogens Arch. Toxicol. 67 49–54
E. Holmes A.W. Nichols J.C. Lindon et al. (1998) ArticleTitleDevelopment of a model for classification of toxin-induced lesions using 1H NMR spectroscopy of urine combined with pattern recognition NMR Biomed. 11 235–244
E. Humpfer M. Spraul A.W. Nicholls J.K. Nicholson J.C. Lindon (1997) ArticleTitleDirect observation of resolved intracellular and extracellular water signals in intact human red blood cells using 1H MAS NMR spectroscopy Magn. Reson. Med. 38 334–336
IARC Monograph Suppl. 7 (1987) IARC Press, Lyon, France, 280 pp
F. Jacolot I. Smion Y. Dreano P. Beaune C. Riche F. Berthou (1991) ArticleTitleIdentification of the cytochrome IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes Biochem. Pharmacol. 41 1911–1919
V.C. Jordan (1982) ArticleTitleMetabolites of tamoxifen in animals and man: identification, pharmacology, and significance Breast Cancer Res. Treat. 2 123–138
V.C. Jordan (1990) ArticleTitleLong-term adjuvant tamoxifen therapy for breast cancer Breast Cancer Res. Treat. 15 125–136
V.C. Jordan (1995) ArticleTitleTamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer Annu. Rev. Pharmacol. Toxicol. 35 195–211
V.C. Jordan K.E. Allen C.J. Dix (1980) ArticleTitlePharmacology of tamoxifen in laboratory animals Cancer Treat. Rep. 64 745–759
V.C. Jordan M.M. Gottardis P.G. Satyaswaroop (1991) ArticleTitleTamoxifen-stimulated growth of human endometrial carcinoma Ann. NY Acad. Sci. 622 439–464
V.C. Jordan C.S. Murphy (1990) ArticleTitleEndocrine pharmacology of antiestrogens as antitumor agents Endocr. Rev. 11 578–610
H. Kappus H.M. Bolt H. Remmer (1972) ArticleTitleDemethylation of mestranol to ethinyloestrodiol in vitro and in vivo Acta. Endocrinol. 71 374–384
H.C. Keun T.M.D. Ebbels H. Antti et al. (2002) ArticleTitleAnalytical reproducibility in 1H NMR-based metabonomic urinalysis Chem. Res. Toxicol. 15 1380–1386
T.A. Kocarek E.G. Schuetz P.S. Guzelian (1990) ArticleTitleDifferentiated induction of cytochrome P450b/e and P450p mRNAs by dose of phenobarbital in primary cultures of adult rat hepatocytes Mol. Pharmacol. 38 440–444
U.J. Kreek R.E. Peterson M.H. Sleisenger G.H. Jeffries (1969) ArticleTitleEffects of ethinylestradiol-induced cholestasis on bile flow and iliary excretion of estradiol and estradiol glucuronide by the rat Proc. Soc. Exp. Biol. Med. 131 646–650
M.C. Larsen P.B. Brake D. Parmar C.R. Jefcoate (1994) ArticleTitleThe induction of five rat hepatic P450 cytochromes by phenobarbital and similarly acting compounds is regulated by a sexually dimorphic, dietary-dependent endocrine factor that is highly strain specific Arch. Biochem. Biophys. 315 24–34
M.C. Larsen C.R. Jefcoate (1995) ArticleTitlePhenobarbital induction of CYP2B1, CYP2B2, and CYP3A1 in rat liver: genetic differences in a common regulatory mechanism Arch. Biochem. Biophys. 321 467–476
E.M. Lenz J. Bright I.D. Wilson S.R. Morgan A.F.P. Nash (2003) ArticleTitleA 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects J. Pharm. Biomed. Anal. 33 1103–1115
Lindon, J.C., Nicholson, J.K. and Everett, J.R. (1999). NMR spectroscopy of biofluids in Webb, G.A. (Ed) Annual reports on NMR spectroscopy, Vol. 38. Academic Press, San Diego, pp. 2–88
J.C. Lindon J.K. Nicholson E. Holmes et al. (2003) ArticleTitleContemporary issues in toxicology. The role of metabonomics in toxicology and evaluation by the COMET project Toxicol. Appl. Pharmacol. 187 137–146
R.R. Love P.A. Newcomb D.A. Wiebe et al. (1990) ArticleTitleEffects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node negative disease J. Natl. Cancer Inst. 82 1327–1332
C. Mani H. Gelboin S. Park R. Pearce A. Parkinson D. Kupfer (1993) ArticleTitleMetabolism of the anitmammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P450 catalyzed N-demethylation and 4-hydroxylation Drug Metab. Dispos. 21 645–656
C. Mani R. Pearce A. Parkinson D. Kupfer (1994) ArticleTitleInvolvement of cytochrome P4503A in catalysis of tamoxifen activation and covalent binding to rat and human liver microsomes Carcinogenesis. 15 2715–2720
K.S. McCully (1969) ArticleTitleVascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis Am. J. Pathol. 56 111–128
K. Millis E. Maas D.G. Cory S. Singer (1997) ArticleTitleGradient high resolution magic angle spinning nuclear magnetic resonance spectroscopy of human adipose tissue Magn. Reson. Med. 38 399–403
S.Y. Mishkin E. Farber R.K. Ho S. Mulay S. Mishkin (1983) ArticleTitleEvidence for the hormone dependency of hepatic hyperplastic nodules: Inhibition of malignant transformation after exogenous 17 beta-estradiol and tamoxifen Hepatology. 3 308–316
D. Moka D. Vorreuther H. Schicha et al. (1998) ArticleTitleBiochemical classification of kidney carcinoma biopsy samples using magic-angle-spinning 1H nuclear magnetic resonance spectroscopy J. Pharm. Biomed. Anal. 17 125–137
J.K. Nicholson J. Connelly J.C. Lindon E. Holmes (2002) ArticleTitleMetabonomics: a platform for studying drug toxicity and gene function Nat. Rev. Drug Discov. 1 153–162
J.K. Nicholson P.J.D. Foxall M. Spraul R.D. Farrant J.C. Lindon (1995) ArticleTitle750 MHz 1H and 1H–13C NMR spectroscopy of human blood plasma Anal. Chem. 67 793–811
J.K. Nicholson J.C. Lindon E. Holmes (1999) ArticleTitle‘Metabonomics’: Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica. 29 1181–1189
J.K. Nicholson M.P. O’Flynn P.J. Sadler A.F. Macleod S.M. Juul P.H. Sonksen (1984) ArticleTitleProton-nuclear-magnetic- resonance studies of serum, plasma, and urine from fasting normal and diabetic subjects Biochem. J. 217 365–375
J.K. Nicholson I.D. Wilson (1987) ArticleTitleHigh resolution nuclear magnetic resonance spectroscopy of biological samples as an aid to drug development Prog. Drug Res. 31 427–479
J.K. Nicholson I.D. Wilson (1989) ArticleTitleHigh resolution proton magnetic resonance spectroscopy of biological fluids Prog. NMR Spectrosc. 21 449–501
J.K. Nicholson I.D. Wilson (2003) ArticleTitleUnderstanding ‘global’ systems biology: metabonomics and the continuum of metabolism Nat. Rev. Drug Discov. 2 668–677
E.F. Nuwaysir D. Daggett V.C. Jordan H.C. Pitot (1996) ArticleTitlePhase II enzyme expression in rat liver in response to the antiestrogen tamoxifen Cancer Res. 56 3704–3710
E.F. Nuwaysir Y.P. Dragan C.R. Jefcoate V.C. Jordan H.C. Pitot (1995) ArticleTitleEffect of tamoxifen administration on the expression of xenobiotic metabolizing enzymes in the rat liver Cancer Res. 55 1780–1786
H. Ochs B. Dusterberg P. Gunzel R. Schulte-Hermann (1986) ArticleTitleEffect of tumor promoting contraceptive steroids on growth and drug metabolizing enzymes in rat liver Cancer Res. 46 1224–1232
C.J. Omiecinski C. Hassett P. Costa (1990) ArticleTitleDevelopmental expression and in situ localization of the phenobarbital-inducible rat hepatic mRNAs for cytochromes CYP2B1, CYP2B2, CYP2C6, and CYP3A1 Mol. Pharmacol. 38 462–470
C.K. Osborne M. Jarman R. McCague E.B. Coronado S.G. Hilsenbeck A.E. Wakeling (1994) ArticleTitleThe importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth Cancer Chemother. Pharmacol. 34 89–95
R.S. Plumb C.L. Stumpf D.G. Gorenstein et al. (2002) ArticleTitleMetabonomics: the use of electrospray mass spectrometry coupled to reversed-phase liquid chromatography shows potential for the screening of rat urine in drug development Rapid Commun. Mass Spectrom. 16 1991–1996
L.A. Poirier (2002) ArticleTitleThe effects of diet, genetics, chemicals on toxicity and aberrant DNA methylation J. Nutr. 132 2336S–2339S
D.G. Robertson M.D. Reily R.E. Sigler D.F. Wells D.A. Paterson T.K. Braden (2000) ArticleTitleMetabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants Toxicol. Sci. 57 326–337
K.S. Solanky N.J.C Bailey B.M. Beckwith-Hall et al. (2003) ArticleTitleApplication of biofluid 1H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile Anal. Biochem. 323 197–204
R.P. Steegers-Theunissen G.H. Boers F.J. Trijels T.K. Eskes (1991) ArticleTitleNeural-tube defects and derangement of homocysteine metabolism N. Engl. J. Med. 324 199–200
H.S. Taper (1978) ArticleTitleThe effect of estradiol-17-phenylpropionate and estradiol benozate on N-nitrosomorpholine-induced liver carcinogenesis in ovariectomized female rats Cancer Lett. 42 462–467
A.R. Tate P.J.D. Foxall E. Holmes et al. (2000) ArticleTitleDistinction between normal and renal cell carcinoma kidney cortical biopsy samples using pattern recognition of 1H magic angle spinning (MAS) NMR spectra NMR Biomed. 13 64–71
A. Tomlins P.J.D. Foxall J.C. Lindon et al. (1998) ArticleTitleHigh resolution magic angle spinning 1H nuclear magnetic resonance analysis of intact prostatic hyperplastic and tumor tissues Anal. Comm. 35 113–115
P. Verhoef M. Stampfer (2001) Epidemiology of vascular and thrombotic associations R. Carmel D.W. Jacobsen (Eds) Homocysteine in health and disease Cambridge University Press Cambridge 357–370
I.R. Wanless A Medline (1982) ArticleTitleRole of estrogens as promoters of hepatic neoplasia Lab Invest. 46 313–320
N.J. Waters E. Holmes A. Williams C.J. Waterfield R.D. Farrant J.K. Nicholson (2001) ArticleTitleNMR and pattern recognition studies on the time-related metabolic effects of a-naphthylisothiocyanate on liver, urine, and plasma in the rat: an integrative metabonomic approach Chem. Res. Toxicol. 14 1401–1412
I.N. White F. De Matteis A.H. Gibbs et al. (1995) ArticleTitleSpecies differences in the covalent binding of [14C]tamoxifen to liver microsomes and the forms of cytochrome P450 involved Biochem. Pharmacol. 49 1035–42
I.N. White A. Davies L.L. Smith S. Dawson F. De Matteis (1993) ArticleTitleInduction of CYP2B1 and 3A1, and associated monooxygenase activities by tamoxifen and certain analogues in the liver of female rats and mice Biochem. Pharmacol. 45 21–30
G.M. Williams M.J. Iatropoulos M.V. Djordjevic O.P. Kaltenberg (1993) ArticleTitleThe triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat Carcinogenesis. 14 315–317
J.D. Yager B.D. Roebuck T.L. Paluszcyk V.A. Memoli (1986) ArticleTitleEffects of ethinyl estradiol and tamoxifen on liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats Carcinogenesis. 7 2007–2014
J.D. Yager R. Yager (1980) ArticleTitleOral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats Cancer Res. 40 3680–3685
J.D. Yager Y.E. Shi (1991) ArticleTitleStimulation of hepatocyte DNA synthesis by ethinyl estradiol Prog. Clin. Biol. Res. 369 53–65
J.D. Yager J. Zurlo C.H. Sewall G.W. Lucier H. He (1994) ArticleTitleGrowth stimulation followed by growth inhibition in livers of female rats treated with ethinyl estradiol Carcinogenesis. 15 2117–2123
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schnackenberg, L., Beger, R.D. & Dragan, Y. NMR-based metabonomic evaluation of livers from rats chronically treated with tamoxifen, mestranol, and phenobarbital. Metabolomics 1, 87–94 (2005). https://doi.org/10.1007/s11306-005-1110-8
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11306-005-1110-8